Search results
Shah Capital proposes new directors for Novavax board By Investing.com
Investing.com· 4 days agoShah Capital, holding a 6.7% stake in vaccine developer Novavax Inc. (NASDAQ: NASDAQ:NVAX), today...
Novavax failed to capitalize on fears surrounding mRNA vaccines, activist investor says
Market Watch· 4 days agovaccine-maker’s management, as it called for an overhaul of the company’s marketing strategy to...
Who can get a Covid booster this spring and how can you book?
BBC via Yahoo News· 6 days agoThe most common include a sore arm, headache, chills, fatigue and nausea. They are part of the...
Only One Harm From mRNA COVID Vaccines, Report Determines
MedPage Today· 4 days agoIndependent reviewers confirmed a causal relationship between the first mRNA COVID-19 vaccines and...
Novavax investor Shah Capital pushes for board shakeup
Reuters via Yahoo News· 4 days ago(Reuters) -A top shareholder of COVID-19 vaccine maker Novavax on Monday said the company has been...
Activist investor blasts Novavax for not using mRNA fears to boost COVID-19 vaccine sales
Quartz· 4 days agoThe activist hedge fund Shah Capital blasted the leadership of Novavax for not leveraging concerns...
The path to a better Tuberculosis vaccine runs through Montana
The Norman Transcript· 4 hours agoA team of Montana researchers is playing a key role in the development of a more effective vaccine against tuberculosis, an infectious disease that has killed more people ...
Analysts Expect Moderna's First-Quarter Sales To Plummet 95% — Is Moderna Stock A Sell?
Investor's Business Daily· 6 hours agoThe company noted that it achieved 48% market share for Covid vaccines in the U.S. during the fall...
Novavax (NASDAQ:NVAX) Trading 3.5% Higher
ETF DAILY NEWS· 6 days agoNovavax, Inc. (NASDAQ:NVAX – Get Free Report)’s stock price traded up 3.5% during mid-day trading on Friday . The stock traded as high as $4.48 and last traded at $4.45. 1,149,644 ...
Hedge fund Shah Capital recommends two new candidates for Novavax board
WSAU Wausau· 4 days ago(Reuters) - U.S.-based hedge fund Shah Capital on Monday recommended the appointment of two new independent directors to the Novavax board. The hedge fund named Suresh Katta ...